Literature DB >> 29378734

Myocardial Injury in Patients With Sepsis and Its Association With Long-Term Outcome.

Jos F Frencken1, Dirk W Donker2, Cristian Spitoni2, Marlies E Koster-Brouwer2, Ivo W Soliman2, David S Y Ong2, Janneke Horn2, Tom van der Poll2, Wilton A van Klei2, Marc J M Bonten2, Olaf L Cremer2.   

Abstract

BACKGROUND: Sepsis is frequently complicated by the release of cardiac troponin, but the clinical significance of this myocardial injury remains unclear. We studied the associations between troponin release during sepsis and 1-year outcomes. METHODS AND
RESULTS: We enrolled consecutive patients with sepsis in 2 Dutch intensive care units between 2011 and 2013. Subjects with a clinically apparent cause of troponin release were excluded. High-sensitivity cardiac troponin I (hs-cTnI) concentration in plasma was measured daily during the first 4 intensive care unit days, and multivariable Cox regression analysis was used to model its association with 1-year mortality while adjusting for confounding. In addition, we studied cardiovascular morbidity occurring during the first year after hospital discharge. Among 1258 patients presenting with sepsis, 1124 (89%) were eligible for study inclusion. Hs-cTnI concentrations were elevated in 673 (60%) subjects on day 1, and 755 (67%) ever had elevated levels in the first 4 days. Cox regression analysis revealed that high hs-cTnI concentrations were associated with increased death rates during the first 14 days (adjusted hazard ratio, 1.72; 95% confidence interval, 1.14-2.59 and hazard ratio, 1.70; 95% confidence interval, 1.10-2.62 for hs-cTnI concentrations of 100-500 and >500 ng/L, respectively) but not thereafter. Furthermore, elevated hs-cTnI levels were associated with the development of cardiovascular disease among 200 hospital survivors who were analyzed for this end point (adjusted subdistribution hazard ratio, 1.25; 95% confidence interval, 1.04-1.50).
CONCLUSIONS: Myocardial injury occurs in the majority of patients with sepsis and is independently associated with early-but not late-mortality, as well as postdischarge cardiovascular morbidity.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  infection; intensive care units; mortality; sepsis; troponin

Mesh:

Substances:

Year:  2018        PMID: 29378734     DOI: 10.1161/CIRCOUTCOMES.117.004040

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  24 in total

1.  Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial.

Authors:  David B Antcliffe; Shalini Santhakumaran; Robert M L Orme; Josie K Ward; Farah Al-Beidh; Kieran O'Dea; Gavin D Perkins; Mervyn Singer; Daniel F McAuley; Alexina J Mason; Mary Cross; Deborah Ashby; Anthony C Gordon
Journal:  Intensive Care Med       Date:  2019-08-19       Impact factor: 17.440

Review 2.  High sensitivity troponin measurement in critical care: Flattering to deceive or 'never means nothing'?

Authors:  Jonathan Hinton; Mark Mariathas; Michael Pw Grocott; Nick Curzen
Journal:  J Intensive Care Soc       Date:  2019-09-05

Review 3.  Long-Term Outcomes in Acute Respiratory Distress Syndrome: Epidemiology, Mechanisms, and Patient Evaluation.

Authors:  Jessica A Palakshappa; Jennifer T W Krall; Lanazha T Belfield; D Clark Files
Journal:  Crit Care Clin       Date:  2021-05-27       Impact factor: 3.879

4.  COVID-19 in heart transplant patients: Case reports from Brazil.

Authors:  Rafaela Vale de Miranda Soriano; Joao Manoel Rossi Neto; Marco Aurelio Finger; Carolina Casadei Dos Santos; Hui Tzu Lin-Wang
Journal:  Clin Transplant       Date:  2021-07-09       Impact factor: 3.456

5.  Association between Troponin I Levels during Sepsis and Postsepsis Cardiovascular Complications.

Authors:  Michael A Garcia; Justin M Rucci; Khanh K Thai; Yun Lu; Patricia Kipnis; Alan S Go; Manisha Desai; Nicholas A Bosch; Adriana Martinez; Heather Clancy; Ycar Devis; Laura C Myers; Vincent X Liu; Allan J Walkey
Journal:  Am J Respir Crit Care Med       Date:  2021-09-01       Impact factor: 30.528

6.  The Role of Glucocorticoid Receptor and Oxytocin Receptor in the Septic Heart in a Clinically Relevant, Resuscitated Porcine Model With Underlying Atherosclerosis.

Authors:  Tamara Merz; Nicole Denoix; Daniela Wigger; Christiane Waller; Martin Wepler; Sabine Vettorazzi; Jan Tuckermann; Peter Radermacher; Oscar McCook
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-14       Impact factor: 5.555

7.  The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients.

Authors:  Kamal Maheshwari; Brian H Nathanson; Sibyl H Munson; Victor Khangulov; Mitali Stevens; Hussain Badani; Ashish K Khanna; Daniel I Sessler
Journal:  Intensive Care Med       Date:  2018-06-05       Impact factor: 17.440

8.  Prognostic Value of High-sensitivity Troponin I in Patients with Septic Shock: A Prospective Observational Study.

Authors:  Ali Jendoubi; Salma Jerbi; Elaa Maamar; Ahmed Abbess; Zied Samoud; Lamia Kanzari; Ilhem Boutiba; Salma Ghedira; Mohamed Houissa
Journal:  Indian J Crit Care Med       Date:  2019-07

9.  Reply: Against Another Nonspecific Marker of Perfusion and Troponin in Sepsis.

Authors:  Jos F Frencken; Dirk W Donker; Olaf L Cremer
Journal:  Ann Am Thorac Soc       Date:  2019-10

10.  Hydrogen Sulfide Attenuated Sepsis-Induced Myocardial Dysfunction Through TLR4 Pathway and Endoplasmic Reticulum Stress.

Authors:  Yu-Hong Chen; Xu Teng; Zhen-Jie Hu; Dan-Yang Tian; Sheng Jin; Yu-Ming Wu
Journal:  Front Physiol       Date:  2021-06-09       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.